Recent chemical and microbiological studies in our laboratories have shown') that sisomicin (1) can be readily modified at the 6'-amino group by alkylation to yield a number of 6'-N-alkylsisomicins which inhibit the growth of sisomicin sensitive organisms and organisms that inactivate sisomicin by 6'-N-acetylation. 2, 3) Further, we have demonstrated that selective N-alkylation of sisomicin, verdamicin (2) and some of the gentamicins (3-'5) at the 1-position provides the corresponding 1-N-alkyl derivatives which possess a microbiological spectrum of activity superior to that of the parent antibacterials. 4, 5) Of particular interest is the finding that alkylation at the 1-position in these antibiotics prevents enzymic adenylylation at the 2"-position by resistant organisms known to inactivate aminoglycoside antibiotics.', ') These results and the fact that netilmicin, the 1-N-ethyl derivative of sisomicin shows less chronic toxicity'-') than sisomicin in animal models prompted us to examine the possibility of replacing the N-methyl group at the 3"-position of sisomicin and gentamicin C2 by other alkyl functions and study its effect on the antimicrobial spectrum. This publication is hence concerned with methods of removal of the 3"-N-methyl group in sisomicin and the gentamicins, and the synthesis and microbiological evaluation of a number of their 3"-N-alkyl derivatives.
3"-De-N-Methylation halogen employed, the product is mono or di-de-N-methyl derivative. Although it was apparent that under these conditions sisomicin (1) and verdamicin (2) would be unstable and cleave to give the pseudodisaccharide garamine,9' the above method appeared attractive for application in the gentamicin class of antibiotics. Thus, treatment of gentamicin C2 (5) with iodine and sodium ace ate in aqueous methanol at 45°C for 24 hours afforded a major product (6) and a minor product (7) as evidenced by tic examination of the reaction mixture. Some unreacted starting material was also present in the mixture. Compounds 6 and 7 were isolated in pure state by column chromatograply.* The most polar component (Compound 6) had [a]D + 159.8° (water) and gave elemental analysis consistent with the formula C19H39N507 required by the 3"-de-N-methyl-gentamicin C2 (6) . The mass spectrum of the compound exhibited a peak at mle 450 attributable to the (M+ + 1) ion."
The presence of deoxystreptamine moiety in the molecule was indicated by the characteristic ions at m1e 191, 173, 163
and 145.11 Also present in the spectrum were the ions at m/e 333, 305 and 287 a-ising from the pseudodisaccharide unit, gentamine C2.11 The absence of peaks at m/e 160 for the garosamine and at mle 350, 322 and 304 for the pseudodisaccharide, garamine, moieties"' along wi.h the presence of the corresponding peaks 14 mass units lower for 3"-de-N-methylgarosamine and 3"-de-N-methylgaramine units confirmed the structure of the compound to be 3"-de-N-methyl-gentamicin C2 (6) . The pmr spectrum of the compound was consistent with the structure. Thus, the anorieric hydrogens H-I' and H-1" appeared at 8 5.15 and 5.13 ppm, respectively with coupling constants of 4 Hz. The 6'-C-methyl and the 4"-C-methyl protons showed signals at 81.09 and 1.21 ppm with the former appearing as a doublet with a spacing of 6.5 Hz and the latter as a ringlet. The H-2" (8 3.7 ppm, J211,311=10 Hz) and H-5," (8 4.09 ppm, J= 12 Hz) resonances were also readily reccgnizable in the spectrum. The yield of 3"-de-N-methyl-gentamicin C2 (6) was 21 %.
The second product (7) which was more polar than gentamicin C2 but less polar than 3"-de-Nmethyl-gentamicin C2 (6) when examined by tlc had [x]D + 173.6° (water). The mass spectrum indicated the compound to be 3"-N-formyl gentamicin C2 (7). Thus, the molecular ion at m/e 491 was in agreement with the composition C21H41N;Os found by elemental analysis. The presence of peaks * During the preparation of this manuscript the de-N-methylation of antibiotic XK-62--2 appeared in a German patent.") In contrast to the methods described in this manuscript, the patented procedures do not lead to selectively N-blocked 3"-de-N-methyl gentamicins (for e.g. 1,3,2',6'-tetra-N-acetyl-3"-de-N-lnethylgentamicin C2) which are the desired intermediates for 3"-N-alkylation with other alkyl groups. Furthermore, as will be apparent from this manuscript, the general photochemical oxidative procedure described here is also suitable for the 1,3,2',6'-tetra-N-acetylsisomicin which cannot be made by the iodine-sodium acetate method. OF ANTIBIOTICS In order to prepare various 3"-N-alkyl derivatives of 3"-de-N-methyl-gentamicin C2 (6), it was thought that 1, 3, 2', 6'-tetra-N-acetyl 3"-de-N-methylgentamicin C2* (11) would be an ideal intermediate which after reductive alkylation at the 3"-position followed by removal of the protecting groups would give the desired products. Compound 11 was prepared from gentamicin C2 (5) equivalents of carbon dioxide, the N-methyl protons were deshielded to 2.8 ppm. It appeared therefore, that the carbonated secondary amino function, also being next to the tertiary alcoholic center, might be the least reactive of the amino groups in gentamicin C2 towards acylating agents under these conditions. Thus, when a solution of gentamicin C2 (5) in aqueous methanol was treated with carbon dioxide followed by acetic anhydride, the major product formed was l ,3,2',6'-tetra-N-acetylgentamicin C2 (12) which was isolated in 60% yield. The structure was apparent from the pmr spectrum which showed the N-methyl resonance at 82.49 ppm indicating no acetylalion at this site.
The four N-acetyl protons appeared at 8 2.01 and 1.99 ppm. The mass spectrum showed the (M+ + 1) ion at m/e 632 and the garosaminyl fragment at m/e 16011', as required ')y the assigned structure. The remainder of the pmr and mass spectral data are given in the experimental section.
Treatment of 1,3,2',6'-tetra-N-acetyl-gentamicin C2 (12) with iodine and sodium acetate as before afforded, as expected, the corresponding de-N-methyl derivative 11 which was isolated in 37 yield after chromatographic purification.
As mentioned earlier, oxidative removal of the 3"-N-methyl group with electrophilic halogens is not applicable to sisomicin type structures (1 and 2) which contain a vinyl ether function. Therefore, we thought that if an oxidative process could be carried out selectively at the Selective tetra-N-acetylation of sisomicin (1) by the carbon dioxide -acetic anhydride method described above afforded 1,3,2',6'-tetra-N-acetyl-sisomicin (13) in 61 % yield. 2,4-Dinitrophenylation of 13 by the standard procedure gave 1,3,2',6'-tetra-N-acetyl-3"-N-(2,4-dinitrophenyl)-sisomicin (14) in near quantitative yield. Photolysis of 14 in dimethylformamide with a 450-watt high pressure mercury lamp (Hanovia) and pyrex filter under nitrogen for 15 hours at room temperature gave two products when examined by tlc which were isolated by column chromatography. The 100 MHz pmr spectrum of the more polar compound 15 in deuterium oxide showed no N-methyl protons. The presence of four N-acetyl groups (8 1.84, 1.91, 1.98 and 1.98 ppm), a tertiary C-methyl group (8 0.96 ppm) and two anomeric protons (8 5.23, H-1", Ji'12"" = 3.5 Hz and 8 5.33 ppm, H-I', Ji'2' = 2.3 Hz) was consistent with the structure for 1,3,2',6'-tetra-N-acetyl-3"-de-N-methyl-3"-N-(2-nitroso-4-nitrophenyl)-sisomicin (15) . The aromatic region of the spectrum showed an AB quartet due to the protons H-5 and H-6 of the 2-nitroso-4-nitrophenyl moiety. The third aromatic proton (H-3) of 15 appeared as a singlet at 8 8.75 ppm. Hydrolysis of 15 with I N sodium hydroxide at 100''C afforded 3"-de-N-methyl-sisomicin (16) whose structure was proven by nmr and mass spectral analysis as in the case of the 3"-de-N-methyl-gentamicin C2 described above (see experimental).
Mild base hydrolysis of 15 afforded 1,3,2',6'-tetra-N-acetyl-3"-de-N-methyl-sisomicin (17) .
The second product of photolysis, compound 18, had near coincidental Rf with the starting material in several solvent systems but could be isolated in pure state after multiple chromatography.
Base hydrolysis of 18 also gave 3"-de-N-methyl-sisomicin (16) (11) was also isolated and characterized as before.
3"-N-Homologues 1,3,2',6'-Tetra-N-acetyl-3"-de-N-methyl-gentamicin C2 (11) was subjected to reductive alkylation at pH 4-4.5 using sodium cyanoborohydride and an aldehyde." In each case, the crude product was deblocked using sodium hydroxide and subjected to chromatographic purification. Thus, the 3"-Nethyl (23), n-propyl (24), n-butyl (25) and (o-aminobutyl (26) derivatives of 3"-de-N-methyl-gentamicin C2 (6) were prepared. All of the above compounds were characterized from their mass spectrometric fragmentation patterns") and pmr spectral properties (see experimental).
Biology
In Table 1 , the minimum inhibitory concentrations (MIC's) of the 3"-de-N-methyl derivatives of gentamicin C2 (6), gentamicin B (22) and sisomicin (16) are given along with those of their parent compounds. Also included in the table, are the MIC's of a number of 3"-N-alkyl-3"-de-N-methyl derivatives. As is apparent from the table all the semisynthetic derivatives have potencies and spectra of antibacterial activity similar to the parent antibiotics from which they are derived.
Experimental
Details of experimental techniques have been published in our earlier papers.i2,ir) 3"-De-N-methyl-gentamicin C2 (6) by the iodine-sodium acetate method Gentamicin C2 (10 g, 21.6 mmol) was dissolved in 50% aqueous methanol (250 ml) and iodine (10 g) and sodium acetate (20 g) were added with stirring. The reaction mixture was maintained at 45°C for 4 hours while the pH of the solution was kept between 8 and 9 by the addition of 1 N sodium hydroxide at hourly intervals. The reaction was allowed to run for an additional 18 hours, after which time additional amounts of iodine (5 g) and sodium acetate (10 g) were added and the pH of the solution adjusted to 9. After a further 6 hours, the solution was decolourized by the addition of aqueous sodium thiosulfate and the mixture was stirred with Amberlite IRC-50 ion-exchange resin in the H+ form (400 ml) unitl all the aminoglycosides were absorbed. The resin was separated and washed carefully with water followed by 2 N ammonium hydroxide. The ammonia eluate was concentrated in vacuo to a residue (8.9 g) which was chromatographed on a column of silica gel (200 g) using the lower phase of a chloroform -methanol -ammonium hydroxide (2:1:1) mixture as the eluent. The first compound to be eluted was gentamicin C2 (1.5 g) which was followed by 3"-N-formyl- The last compound to be eluted from the column was 3"-de-N-methyl-gentamicin C2 (6) Dry ice (8.8 g) was added to a stirred solution of gentamicin C2 (23.2 g, 50 mmol) in 50" aqueous methanol (1.5 liters). After 10 minutes at room temperature, a I vt solution of ace-ic anhydride in tetrahydrofuran was added dropwise (200 ml). Ten minutes after completion of the addition, thin-layer chromatography on silica gel using chloroform -methanol -ammonium hydroxide (30: 10: 1) as the solvent system indicated the presence of one major spot and one minor spot in the ratio of about 90: 10. Work-up in the usual manner and isolation of the major product by column chromatography on silica gel (1:50 ratio) using the above solvent system afforded pure 1,3,2',6'-tetra-N-acetylgentamicin C2 (12) .2 g) and iodine (2.4 g) were added to a solution of tetra-N-acetyl-gentamicin C2 (1.75 g) in 50 % aqueous dioxane (40 ml). The mixture was stirred in a nitrogen atmosphere at 40°C. Amberlite IRA 401S (OH-) resin was introduced to bring the pH of the solution to 10.4. After 20 minutes, additional amounts of the resin was added to bring the pH of the solution to 8.4. After 21 hours, the solution was filtered and the filtrate treated with Amberlite IR-120 (H+) resin to absorb the products completely. After washing the resin with water, the resin was washe3 with 3 % ammonium hydroxide solution. The ammonia solution was evaporated in vacuo E.nd the residue lyophilized to give crude products which were subjected to chromatography on silica gel (50 g) using chloroform -methanol -ammonium hydroxide (30: 10: 0.5) as the eluant. The pun; fractions containing the product were pooled, concentrated and lyophilized to give 0. Anal. Calcd. for C27H45N5011•H20: C, 51.17; H, 7.47; N, 11.05% Found: C, 50.95; H, 7.30; N, 11.25 1,3,2',6'-Tetra-N-acetyl-3"-N-(2,4-dinitrophenyl)-sisomicin (14) 2,4-Dinitrofluorobenzene (9.4 ml) was added dropwise to a stirred and cooled solution of 1 ,3,2',6'-tetra-N-acetyl sisomicin (22.8 g) (13) and sodium carbonate (7.8 g) in water (40 ml) and methanol (100 ml). The reaction mixture was stirred for 18 hours at room temperature after which time the solids were removed by filtration, washed with methanol and the combined filtrates concentrated in vacuo. The concentrate was chromatographed on 900 g of silica gel using a solvent system consisting of chloroform -methanol -ammonium hydroxide (30: 10: 1). The homogeneous fractions containing the product were pooled and concentrated to dryness to yield 23 g of pure 14, 2 g) was dissolved in dimethylformamide (300 ml) and the solution irradiated with a 450-watt high pressure mercury lamp (Hanovia) through a pyrex filter while bubbling nitrogen through the solution. After 5 hours, the solvent was removed by evaporation in high vacuum at 50°C and the residue chromatographed on silica gel (200 g) using chloroform -methanol -ammonium hydroxide (30: 10: 1) as the solvent system. Work-up in the usual manner gave two products, fraction A (0.84g) and fraction B (0.63g) which were combined, dissolved in I N sodium hydroxide (60 ml) and the solution heated under nitrogen and refluxed for 24 hours. The antibiotic was adsorbed on Amberlite IRC-50 ion-exchange resin in the proton form, the resin was washed with water followed by 7 % ammonium hydroxide. The ammonia wash was concentrated and the residue chromatographed on silica gel using chloroform -methanol -ammonium hydroxide 3"-De-N-methyl-gentamicin B Gentamicin B (9.64 g) was converted to 1,3,6'-tri-N-acetyl-gentamicin B in a manner similar to that described for the preparation of 12. The product was converted as in the preparation of 14, to 1,3,6'-tri-N-acetyl-3"-N-(2,4-dinitrophenyl)-gentamicin B (23) in 55% overall yield from gentamicin B. The above compound (2 g) was photolyzed in 450 nil methanol as mentioned above for 15 hours. The solvent was removed in vacuo and the residue chromatographed on 100 g silica gel using chloroform -methanol -ammonium hydroxide (2: 1: 0.35) as the eluant. The two products of photolysis, fraction A (0.478 g) and fraction B (1.168 g) were pooled together and after removal of the solvent in vacuo, the residue was dissolved in 45 ml 1 N sodium hydroxide and heated under reflux in a nitrogen atmosphere for 24 hours. The cooled solution was neutralized to pH 7 with dilute sulfuric acid and concentrated to dryness in vacuo. The residue was trituratec with a mixture of chloroform -methanol -ammonium hydroxide (3: 4: 2). The solids were removed by filtration, the filtrate concentrated and chromatographed on 200 g silica gel using the same solvent system. Fractions containing the pure product were worked-up in the usual manner to give 0. Found: C, 48.35; H, 5.94; N, 11.80% The above compound, 2 g, was photolyzed in 450 ml of methanol as described in the above procedures for 13 hours. The solvent was removed in vacuo and the residue chromatographed on 100 g of silica gel using a mixture of chloroform -methanol -ammonium hydroxide (30: 10: 1). The two products of photolysis, fraction A (0.48 g) and fraction B (0.9 g) were combired and dissolved in 45 ml of 1 N sodium hydroxide. The basic solution was refluxed for 24 hour: under nitrogen and work-up as in the case of 22 afforded pure 3"-de-N-methyl-gentamicin Cs in 40 yield from gentamicin C2, identical with the product obtained from the iodine-sodium acetate method.
The 3"-N-alkyl derivatives of 3"-de-N-methyl-gentamicin C2 were prepared by the; general method given below for the preparation of 3"-N-butyl-3"-de-N-methyl gentamicin C2 (24).
3"-N-Butyl-3"-de-N-methyl-gentamicin Q(24) 1,3,2',6'-Tetra-N-acetyl-3"-de-N-methyl gentamicin C2 (11) (630 mg, 1 mmole) was dissolved in 20 ml 90% aqueous methanol and chilled in ice water. Butyraldehyde (0.2m],, was added and the pH was adjusted to 4.5 with dilute hydrochloric acid. Sodium cyanoborohydride (120 mg) was added to the stirring solution. TIc after 30 minutes (chloroform -methanol -:is °,o ammonium hydroxide, 25: 10: 2.2) showed '-60'/0/ conversion. The pH was adjusted to 4.5 and additional 0.1 ml aldehyde and sodium cyanoborohydride (60 nag) were added. The above procedure was repeated once again and showed no starting material left. The reaction mixture was evaporated to about 2 ml, diluted in 15 ml 2 N sodium hydroxide and refluxed 18 hours under nitrogen.
The antibiotic was absorbed onto 40 ml Amberlite IR 120 proton form ion-exchange resin, the resin was washed with water and the crude antibiotic eluted with 4 portions of 7°o ammonium hydroxide. Freeze drying gave 428 mg of crude product. The product was chromatographed on 45 g of silica gel using chloroform -methanol -ammonium hydroxide (25: 10::.2), taking 5-ml fractions, 10 fractions per hour. 
